CENTER FOR WOMEN'S HEALTH AND WELLNESS

School of Health and Human Sciences

October 14th, 2021 – 4:00-5:30p.m. (Lecture with Reception to Follow)
Register here by Oct 8th, 2021.
EUC Auditorium


Exercise and Yoga as Adjuvant Therapy for Cancer: A Women’s Health Perspective

Karen M. Mustian, Ph.D., M.A., M.P.H.

Dean’s Distinguished Endowed Professor of Oncology and Surgery
Co-Director, Wilmot Cancer Institute Cancer Prevention and Control Research Program
Co-Director and MPI of the University of Rochester Cancer Center NCORP Research Base
Director, Human Performance Clinical Research Laboratory
University of Rochester School of Medicine and Dentistry


Karen M. Mustian
Bio – Dr. Mustian is an energetic, passionate, world-traveling yogi, scuba diver, foodie and world-renowned scientist, who spends her life working to help good people through lousy times when they encounter cancer! Dr. Mustian is an international leader in the fields of Cancer Control and Survivorship, Behavioral Oncology, Exercise Oncology, Geriatric Oncology, and Gender, Sexuality and Women’s Health. Her research is in the area of cancer control and survivorship with primary foci on investigating the influence of exercise (i.e., exercise, yoga, tai chi) on symptoms and side effects (acute, chronic and late) stemming from cancer and its treatments.

Dr. Mustian is a leader in conducting large, multi-center, phase III clinical trials testing exercise and behavioral interventions among cancer patients and survivors with over 19 years of experience at the University of Rochester Wilmot Cancer Institute. She is the PI for several local and nationwide randomized clinical trials funded by the NCI, NCCAM, OCCAM, NINR and DOD. To date, she has acquired over $80 million in research funding and authored over 150 articles and book chapters in the field of exercise and cancer control. Dr. Mustian has been recognized for her excellence in research and leadership with more than 43 awards nationally and globally.

Dr. Mustain is a new federally appointed member of the National Cancer Institute (NCI) Board of Scientific Advisors, and member of the NCI Symptom Management and Quality of Life Steering Committee and Cardiotoxicity Task Force. She has contributed to multiple national and international panels to establish clinical cancer treatment guidelines, including the American Society of Clinical Oncology (ASCO) Fatigue Treatment Guidelines (Chair), the ASCO Evaluation & Management of Vulnerabilities in Older Patients Treatment Guidelines (member), the Integrative Medicine in Oncology Treatment Guidelines (member) and the Multinational Association of Supportive Care in Cancer International Cancer-Related Fatigue Treatment Guidelines Committee (Chair).